Ecke, Ines <br/><br/>
Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.  [electronic resource] 

 -  Cancer research  Feb 2009 
 - 887-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-08-0946  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Azacitidine--administration & dosage<br/>DNA (Cytosine-5-)-Methyltransferase 1<br/>DNA (Cytosine-5-)-Methyltransferases--antagonists & inhibitors<br/>DNA Methylation<br/>Decitabine<br/>Gene Expression--drug effects<br/>Gene Silencing<br/>Histone Deacetylase Inhibitors<br/>Histone Deacetylases--metabolism<br/>Histones--metabolism<br/>Medulloblastoma--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Muscle, Skeletal--drug effects<br/>Patched Receptors<br/>Patched-1 Receptor<br/>Receptors, Cell Surface--genetics<br/>Rhabdomyosarcoma--drug therapy<br/>Valproic Acid--administration & dosage